On the other hand, pairs such as CCR1-CCL4 are always co-upregulated but with different prognostic values; i.e., they are associated to higher survival in melanoma (RAS and BRAF hotspot mutant subtypes), and to lower survival in genomically stable gastric cancer (GI.GS subtype; Figure 4E). Here, CCL4 is linked to gastric cancer.